bioAffinity Technologies, Inc. (BIAF) 是一家上市公司 属于 医疗保健 板块，经营于 Medical - Diagnostics & Research 行业. 公司总部位于 San Antonio, TX, 美国. 现任CEO为 Maria Zannes.
BIAF 拥有 IPO日期为 2022-09-01, 57 名全职员工, 在 NASDAQ Capital Marke, 市值为 $12.64M.
bioAffinity Technologies, Inc., a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat cancer at the cellular level. The company was founded in 2014 and is based in San Antonio, Texas.
